Global Heparin Anticoagulant Market Research Report 2021

Anticoagulants are the cornerstone therapy for thrombosis prevention and treatment. The anticoagulant activity of heparin is heterogeneous with respect to molecular size, and pharmacokinetic properties. Its molecular weight ranges from 3000 to 30 000 Da, with a mean molecular weight of 15 000 Da. The use of heparin ranges from anti-inflammatory, allergic disorders and anti-tumor applications to prevention of infectious disease and use as nanocarriers for drug delivery. Advantages of heparin such as immediate onset of action, short half-life, simple laboratory monitoring, ability to be reversed (protamine), and low cost have led to its broad use.

The global Heparin Anticoagulant market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Heparin Anticoagulant volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Heparin Anticoagulant market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Heparin Anticoagulant Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Unfractionated Heparin (UF)
Low Molecular Weight Heparin (LMWH)
Ultra-low Molecular Weight Heparin (ULMWH)

Segment by Application
Assisted Living Facilities
Home Healthcare
Hospitals
Nursing Homes and Private Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Aspen Pharmacare Holdings
Baxter International
GlaxoSmithKline
Dr. Reddy’s Laboratories
Fresenius Kabi
Leo Pharma
Mylan
Novartis
Pfizer
Sanofi
Syntex
Teva

Frequently Asked Questions